Our Team

Paul Lucas PHD, Co-Founder and Chief Science Officer

Paul Lucas PHD, Co-Founder and Chief Science Officer

Paul was previously the Director of Orthopedic Research and an Associate Professor at the Department of Orthopedic Surgery New York Medical College and Westchester Medical Center, Valhalla, NY. Dr. Lucas has had an extensive career in academia and medical research and is considered a luminary in the field of stem cell sciences.

LinkedIn

 Chad Ronholdt, CEO

Chad Ronholdt, CEO

Chad's distinguished career has resulted in the development, validation and
commercialization of fifteen regenerative medicine orthobiologic and cell-based products for the
orthopedic spine, trauma, sports medicine, and wound care markets. He has been invited to major symposia to present on topics ranging from complex microbiology validations, stem cell characterization methodologies, FDA compliance requirements and operational strategies.

LinkedIn

Christian Johnson, Co-Founder

Christian Johnson, Co-Founder

Chris has been successful in real estate and corporate finance for over 30 years and in biotech for the last five years. He resides in Los Angeles, CA.

Scott Brovsky, Co-Founder and COO

Scott Brovsky, Co-Founder and COO

Scott has helped bring 8 startups in the Biotech, Agtech and Climate tech verticals out of the labs at the University of California, Riverside and other Research Universities. He has been a Co-Founder or Founding Executive of 6 tech startups including LITPro, Muti Labs, Stan Lee Media, Global Ticket Exchange, and Industrial Strength Network.

LinkedIn

Partners

Catalent

Catalent

Catalent is a fortune 500 public company that is guiding acceptance of our MASC’s by the FDA and serving as the ASC Biosciences GMP Cell manufacturer.

Wilson Sonsini

Wilson Sonsini

The law firm of Wilson Sonsini is doing all of ASC Bio's patent and IP strategy work.

Contact ASC Biosciences

 

Have a question or comment? Contact ASC Biosciences to get in touch with our team.

ASC Biosciences is a development stage Tissue Engineering and Regenerative Medicine Company that has developed a proprietary allogeneic adult Stem Cell Platform capable of regenerating nearly every tissue in the human body. The Platform is comprised of Multipotent Adult Stem Cells (“MASCs”) patented by New York Medical College and licensed by ASC Biosciences. MASCs will differentiate into cartilage, bone, tendon, muscle, ligament, fat, blood vessels, nerves, and skin with an unlimited ability to divide in the undifferentiated state thereby providing whatever numbers of cells are needed to repair the damage.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.